Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
Titel:
Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
Auteur:
Sugimoto, T. Matsumoto, T. Hosoi, T. Miki, T. Gorai, I. Yoshikawa, H. Tanaka, Y. Tanaka, S. Fukunaga, M. Sone, T. Nakano, T. Ito, M. Matsui, S. Yoneda, T. Takami, H. Watanabe, K. Osakabe, T. Okubo, N. Shiraki, M. Nakamura, T.